Dyve Biosciences to Present at the 34th Annual Roth Conference
CAMARILLO, Calif., March 09, 2022 (GLOBE NEWSWIRE) — Dyve Biosciences, Inc. (“Dyve”), a clinical-stage biotech…
News
Running for Research – Prader-Willi Syndrome to Fund Multi-Center Study of DCCR in Early Phase Prader-Willi Syndrome
REDWOOD CITY, Calif., March 09, 2022 (GLOBE NEWSWIRE) — Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO),…
PDS Biotechnology Announces Conference Call and Webcast for Fourth Quarter and Full Year 2021 Financial Results
FLORHAM PARK, N.J., March 09, 2022 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB), a…
Mustang Bio Announces City of Hope, University of Alabama at Birmingham and Nationwide Children’s Hospital Abstract Accepted for Late-Breaker Poster Presentation at the American Association for Cancer Research (AACR) Annual Meeting 2022
WORCESTER, Mass., March 09, 2022 (GLOBE NEWSWIRE) — Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a…
C4 Therapeutics Announces FDA Orphan Drug Designation for CFT8634 for the Treatment of Soft Tissue Sarcoma
WATERTOWN, Mass., March 09, 2022 (GLOBE NEWSWIRE) — C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a…
Jane Huang, M.D., Joins Prelude Therapeutics as President and Chief Medical Officer
WILMINGTON, Del., March 09, 2022 (GLOBE NEWSWIRE) — Prelude Therapeutics Incorporated (Nasdaq: PRLD) a clinical-stage…
Denali Therapeutics Announces Initiation of Phase 1/2 Clinical Trial of DNL593 (PTV:PGRN) for Frontotemporal Dementia-Granulin (FTD-GRN)
SOUTH SAN FRANCISCO, Calif., March 09, 2022 (GLOBE NEWSWIRE) — Denali Therapeutics Inc. (NASDAQ: DNLI),…
Cullinan Oncology to Present at the Barclays Global Healthcare Conference
CAMBRIDGE, Mass., March 09, 2022 (GLOBE NEWSWIRE) — Cullinan Oncology, Inc. (Nasdaq: CGEM) (“Cullinan”), a biopharmaceutical…
Genenta Data Presentation at AACR to Describe On-Target Biological Activity of Temferonâ„¢ in Unmethylated Glioblastoma Multiforme
Data to be presented at the 2022 annual meeting of American Association for Cancer Research…
Freeline Announces First Patient Dosed in the Phase 1/2 B-LIEVE Dose-Confirmation Trial in Hemophilia B
On track to complete dosing of the first cohort and share initial data by the…
Akari Therapeutics Announces New Data Supporting Use of Drug Candidate Votucalis Targeting Difficult to Treat Pain and Itch
Broad-acting antihistamine has potential in number of disease areas with unmet clinical need NEW YORK…
AIM ImmunoTech Announces Abstract from University of Pittsburgh Medical Center Accepted for Presentation at the AACR 2022 Annual Meeting
OCALA, Fla., March 09, 2022 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE: American AIM) (“AIM”…
Revolution Medicines Announces Seven Oral Presentations at the Upcoming American Association for Cancer Research Annual Meeting 2022
Pipeline of Development-Stage RAS(ON) Inhibitors to be Highlighted in Four Presentations in “Targeting the RAS…
Ocugen, Inc. to Present at the 34th Annual ROTH Conference
MALVERN, Pa., March 09, 2022 (GLOBE NEWSWIRE) — Ocugen, Inc. (NASDAQ: OCGN), a clinical-stage biopharmaceutical…
AIM ImmunoTech Announces Abstracts from Roswell Park Comprehensive Cancer Center Accepted for Presentation in a Late-Breaking Poster Session at the AACR 2022 Annual Meeting
OCALA, Fla., March 09, 2022 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE: American AIM) (“AIM”…
Fresche Solutions Acquires Trinity Guard to Deliver Cutting-edge IBM i Security, Compliance & Intrusion Detection
The acquisition adds newly developed, advanced software that identifies and protects IBM i and Linux…
Axiad and Venafi Partner to Provide Passwordless Access for Users and Machines
Alliance simplifies lifecycle management of thousands of users and machine identities across the enterprise SANTA…
Pikmykid Prioritizes School Safety with Expansion of Features
The school safety and dismissal platform continues growth with the addition of its safety panic…
VERB Executives Answer Investor Questions on New Livestream Shopping Platform MARKET in Latest Interviews
VERB COO Denise Butler and VERB SVP, Business Development, Angel Cicerone Provide Updates on VERB’s…
2022 State of the Cloud Report by Flexera
Cloud strategy is a must for enterprises to scale, be agile, increase revenue and business…